Loading organizations...
Key people at Jointown Pharmaceutical Group.
Jointown Pharmaceutical Group is a technology-driven comprehensive service provider for the pharmaceutical industry, distributing medical products, pharmaceuticals, and equipment, based in Wuhan, Hubei, China. The publicly traded company (SHA: 600998) operates extensive wholesale, retail, and logistics services, serving hospitals, pharmacies, and healthcare providers primarily across China, with some overseas expansion. With approximately 30,141 employees, Jointown reported revenue of $20.8 billion, reflecting its significant scale in the healthcare sector. Under the leadership of founder and Chairman Liu Baolin, the group has expanded internationally, notably acquiring the New York pharmacy chain Starside Drugs in 2018. Jointown Pharmaceutical Group was officially founded on March 28, 2000, by Liu Baolin. Its business model centers on publicly traded company generating revenue through pharmaceutical distribution, wholesale, medical equipment sales, and related services.
Key people at Jointown Pharmaceutical Group.
Jointown Pharmaceutical Group has 1 tracked investment across 1 company. The latest tracked deal is $60.0M Series A in Singlera Genomics in March 2018.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Mar 28, 2018 | Singlera Genomics | $60.0M Series A | Green Pine Capital Partners, Prosperico Ventures | Lilly Asia Ventures, UCF Medical Investment |